These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 4147120)
1. Metabolism of salicylazosulfapyridine in healthy subjects and in patients with ulcerative colitis. Effects of colectomy and of phenobarbital. Schröder H; Lewkonia RM; Price Evans DA Clin Pharmacol Ther; 1973; 14(5):802-9. PubMed ID: 4147120 [No Abstract] [Full Text] [Related]
2. Is plasma level monitoring of sulfasalazine indicated in the treatment of Crohn's disease or ulcerative colitis? Fischer C; Klotz U Ther Drug Monit; 1980; 2(2):153-8. PubMed ID: 6132473 [No Abstract] [Full Text] [Related]
3. The role of the colon in the metabolism of salicylazosulphapyridine. Das KM; Eastwood MA; McManus JP; Sircus W Scand J Gastroenterol; 1974; 9(2):137-41. PubMed ID: 4150441 [No Abstract] [Full Text] [Related]
4. Acetylation polymorphism of sulfapyridine in patients with ulcerative colitis and Crohn's disease. Das KM; Eastwood MA Clin Pharmacol Ther; 1975 Nov; 18(5 Pt 1):514-20. PubMed ID: 241531 [TBL] [Abstract][Full Text] [Related]
5. [40 years of salazosulfapyridine. Is end in sight?]. van Hees PA; van Tongeren JH Ned Tijdschr Geneeskd; 1982 Oct; 126(44):2014-8. PubMed ID: 6129576 [No Abstract] [Full Text] [Related]
6. Letter: Salicylazosulfapyridine in clinical practice. Daz KM Gastroenterology; 1974 Feb; 66(2):326. PubMed ID: 4149356 [No Abstract] [Full Text] [Related]
7. [Possible mechanism of action of Azulfidine/Salazopyrin]. Campbell DE Z Gastroenterol Verh; 1981 Jun; 19():15-20. PubMed ID: 6168126 [No Abstract] [Full Text] [Related]
8. [Estimations of the serum levels of sulfapyridine on patients treated with sulfasalazin (author's transl)]. Eitner K; Hippius M; Reinicke C Dtsch Z Verdau Stoffwechselkr; 1982; 42(1):14-9. PubMed ID: 6122556 [TBL] [Abstract][Full Text] [Related]
9. Sulphasalazine in inflammatory bowel disease: recent advances. Cooper BT N Z Med J; 1986 Oct; 99(811):757-9. PubMed ID: 2877428 [No Abstract] [Full Text] [Related]
10. [Salazosulfapyridine: old and new therapy concepts in inflammatory bowel diseases]. Allgayer H; Kruis W Dtsch Med Wochenschr; 1985 Nov; 110(47):1827-9. PubMed ID: 2866083 [No Abstract] [Full Text] [Related]
11. [Side effects of salicylazosulfapyridine therapy]. Miller B Dtsch Med Wochenschr; 1980 Nov; 105(46):1596-7. PubMed ID: 6108200 [No Abstract] [Full Text] [Related]
12. Hemolysis during salicylazosulfapyridine therapy. van Hees PA; van Elferen LW; van Rossum JM; van Tongeren JH Am J Gastroenterol; 1978 Nov; 70(5):501-5. PubMed ID: 33552 [TBL] [Abstract][Full Text] [Related]
13. [Ulcerative rectocolitis: current clinical and therapeutic concepts]. Larizza D; Boni R Clin Ter; 1982 Nov; 103(3):303-18. PubMed ID: 6129939 [No Abstract] [Full Text] [Related]
14. [Pulmonary diffusing capacity disorder in nonspecific intestinal inflammations unexplainable by acetylation phenotype or treatment with sulfasalazine]. Bures J; Horácek J; Tilser P; Fixa B; Komárková O; Tichý M; Zaydlar K; Král B Cas Lek Cesk; 1986 Jul; 125(29):905-9. PubMed ID: 2873894 [No Abstract] [Full Text] [Related]